Showing results (1301-1310 of 2,158) with videos related to
Sort By:
Pageof 216
Journal of Biopharmaceutical Statistics|October 8, 2004
Cross-validation for linear model with unequal variances in genomic analysisLi Li, Shein-Chung Chow, Woollcott SmithJournal of Biopharmaceutical Statistics|November 1, 1994
Statistical considerations for design and analysis of a multiperiod crossover study to compare two treatments for migraine headacheR L Davis, G G KochJournal of Biopharmaceutical Statistics|November 1, 1994
Evaluation of alternative statistical models for crossover studies to demonstrate caffeine adjuvancy in the treatment of tension headacheG G Koch, I A Amara, J MacMillanJournal of Biopharmaceutical Statistics|November 1, 1994
Estimation and hypothesis testing of treatment effects in animal reproductive toxicology studiesK T Tsai, J P HsuJournal of Biopharmaceutical Statistics|January 16, 2010
Development of biosimilars--pharmacokinetic and pharmacodynamic considerationsYow-Ming C Wang, Andrew T ChowJournal of Biopharmaceutical Statistics|January 16, 2010
Adaptive Bayesian design for phase I dose-finding trials using a joint model of response and toxicityMeihua Wang, Roger DayJournal of Biopharmaceutical Statistics|February 26, 2010
Sample size allocation to regions in a multiregional trialHiroyuki UesakaJournal of Biopharmaceutical Statistics|February 26, 2010
Drug-drug interaction prediction assessmentJihao Zhou, Zhaohui Qin, Quinney K Sara, et al.Journal of Biopharmaceutical Statistics|February 26, 2010
Baseline observation carry forward: reasoning, properties, and practical issuesJun Shao, David C Jordan, Yili L PritchettJournal of Biopharmaceutical Statistics|February 26, 2010
A novel Gibbs maximum a posteriori (GMAP) approach on Bayesian nonlinear mixed-effects population pharmacokinetics (PK) modelsSeongho Kim, Stephen D Hall, Lang LiPageof 216